Other
Gut Microbiota
0
Pipeline Programs↗
6
Active Trials↗
1
Companies Involved↗
Gut Microbiota is an early-stage landscape with 0 programs across 1 company. The most active players are Biogen.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
32
clinical trials
Completed13 · 41%
Unknown status12 · 38%
Recruiting4 · 13%
Terminated1 · 3%
Not yet recruiting1 · 3%
Enrolling by invitation1 · 3%
Clinical Trials
Trial Activity
32 trials
Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota
Completed·—·N/A·NCT01473368·53 enrolled
Gut Microbiota, PGx and INSTIs Response
Completed·CCliniques universitaires Saint-Luc- Université Catholique de Louvain·N/A·NCT04805944·180 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)